Drug Discovery in Infectious Disease Training
传染病培训中的药物发现
基本信息
- 批准号:10380751
- 负责人:
- 金额:$ 20.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-12 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
While treatments for eradicating some infectious diseases have been successful, there is still a large gap in the
treatment of infections caused by bacteria, viruses, fungi and parasites, in particular as drug resistance continues
to grow as a problem. To address this evolving issue, scientists are needed who are trained to understand how
pathogens interact with the host, in order to better uncover opportunities and strategies for drug discovery. This
training program’s goal is to address this need by providing qualified graduate students with broad training in
infectious diseases and drug discovery, complemented by professional development opportunities, that prepares
them for a long productive career in infectious disease related research. The training program includes 21 faculty
members from 6 departments across 4 different colleges at Purdue University. These faculty members have
diverse and complementary research interests in infectious disease, drug discovery and drug delivery, structural
biology, and molecular biology. All of these faculty members are part of the Purdue Institute of Inflammation,
Immunology and Infectious Disease and the Purdue Institute for Drug Discovery. These institutes bring faculty
and trainees together through shared research space, a seminar series, journal clubs, and social events,
resulting in a unique and supportive training environment for the “Drug Discovery in Infectious Disease Training”
program. In this program, students will develop expertise both in infectious disease and in drug discovery.
Specifically, trainees will take a course focused on: 1) infectious diseases and drug discovery and 2) biological
membranes (a common theme of pathogen entry, exit and replication). To promote responsible, rigorous and
reproducible research practices, students will complete courses in statistical analysis and the responsible
conduct in research. To develop written communication skills, trainees also will take a grant-writing course,
where they participate in a collaborative, active learning environment to gain feedback on the development of an
NIH F31 style proposal. Additional training activities include participating in a seminar series, attending
regional/national scientific meetings, and completing a capstone project in the area of drug discovery in infectious
disease. In completing this semester-long capstone project, trainees will build teamwork, critical thinking and
data analysis skills, all while working in the context of drug discovery and infectious disease. The capstone
project will be complemented with networking and learning opportunities with industrial partners who are
developing new drugs for infectious diseases. Further, fellows have the opportunity to engage in entrepreneurial
training, an important aspect of academic drug discovery. Using a jointly developed Individual Development Plan,
the trainees and mentors will create a training plan that is tailored towards the students’ training needs and
career goals. In the end, the training program will have helped students work towards their desired career goals,
while also developing a workforce with a unique skillset for addressing the challenges of discovering therapies
for infectious disease.
!
项目概要
虽然根除某些传染病的治疗方法已取得成功,但仍存在很大差距
治疗由细菌、病毒、真菌和寄生虫引起的感染,特别是在耐药性持续存在的情况下
为了解决这个不断发展的问题,需要经过培训的科学家了解如何解决这一问题。
病原体与宿主相互作用,以便更好地发现药物发现的机会和策略。
培训计划的目标是通过为合格的研究生提供广泛的培训来满足这一需求
传染病和药物发现,辅以专业发展机会,为
培训项目包括 21 名教员,以帮助他们在传染病相关研究领域取得长期富有成效的职业生涯。
这些教师来自普渡大学 4 个不同学院的 6 个系。
在传染病、药物发现和药物输送、结构性
所有这些教职人员都是普渡大学炎症研究所的一部分,
免疫学和传染病以及普渡大学药物发现研究所都拥有教职人员。
通过共享研究空间、研讨会系列、期刊俱乐部和社交活动与学员一起,
为“传染病培训中的药物发现”提供了独特且支持性的培训环境
在该计划中,学生将培养传染病和药物发现方面的专业知识。
具体来说,学员将学习以下课程:1) 传染病和药物发现,2) 生物学
膜(病原体进入、退出和复制的共同主题)。
可重复的研究实践,学生将完成统计分析和负责的课程
为了培养书面沟通技巧,学员还将参加资助写作课程,
他们参与协作、主动的学习环境,以获得有关发展的反馈
NIH F31 风格提案的其他培训活动包括参加系列研讨会、出席。
区域/国家科学会议,并完成传染病药物发现领域的顶点项目
在完成这个为期一个学期的顶点项目时,学员将建立团队合作、批判性思维和能力。
数据分析技能,同时在药物发现和传染病的背景下工作。
该项目还将提供与工业合作伙伴建立联系和学习的机会,这些合作伙伴
此外,研究员还有机会参与创业。
培训是学术药物发现的一个重要方面,使用共同制定的个人发展计划,
学员和导师将根据学生的培训需求制定培训计划
最终,培训计划将帮助学生实现他们期望的职业目标,
同时还培养一支具有独特技能的员工队伍,以应对发现疗法的挑战
用于传染病。
!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Virgil Stahelin其他文献
Robert Virgil Stahelin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Virgil Stahelin', 18)}}的其他基金
Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2
阐明 SARS-CoV-2 的组装和出芽机制
- 批准号:
10595342 - 财政年份:2022
- 资助金额:
$ 20.74万 - 项目类别:
Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2
阐明 SARS-CoV-2 的组装和出芽机制
- 批准号:
10707286 - 财政年份:2022
- 资助金额:
$ 20.74万 - 项目类别:
Computational and Biophysical Analysis of the Filovirus Matrix Protein System
丝状病毒基质蛋白系统的计算和生物物理分析
- 批准号:
10317727 - 财政年份:2021
- 资助金额:
$ 20.74万 - 项目类别:
Computational and Biophysical Analysis of the Filovirus Matrix Protein System
丝状病毒基质蛋白系统的计算和生物物理分析
- 批准号:
10448452 - 财政年份:2021
- 资助金额:
$ 20.74万 - 项目类别:
Computational and Biophysical Analysis of the Filovirus Matrix Protein System
丝状病毒基质蛋白系统的计算和生物物理分析
- 批准号:
10669678 - 财政年份:2021
- 资助金额:
$ 20.74万 - 项目类别:
Investigation of the role of phosphatidic acid metabolism in filovirus budding
磷脂酸代谢在丝状病毒出芽中的作用的研究
- 批准号:
9979431 - 财政年份:2020
- 资助金额:
$ 20.74万 - 项目类别:
A New Targeting Approach to Inhibit Budding of the Ebola Virus
抑制埃博拉病毒萌芽的新靶向方法
- 批准号:
9763445 - 财政年份:2018
- 资助金额:
$ 20.74万 - 项目类别:
相似国自然基金
诊疗一体化PS-Hc@MB协同训练介导脑小血管病康复的作用及机制研究
- 批准号:82372561
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于自监督学习的脑电特征表达预训练模型研究
- 批准号:62376098
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
HMGCS2调控巨噬细胞训练免疫对动脉粥样硬化斑块“维稳”的机制研究
- 批准号:82373884
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
面向开放环境的现实人物检索及其分布式并行训练方法研究
- 批准号:62302161
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深度神经网络的超图表征学习、训练优化与鲁棒性研究
- 批准号:62376153
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Positioning Mason's Regional Biocontainment Laboratory for Effective Pandemic Preparedness
梅森的区域生物防护实验室定位为有效的流行病防范
- 批准号:
10793382 - 财政年份:2023
- 资助金额:
$ 20.74万 - 项目类别:
Harnessing polymicrobial interactions in the catheterized urinary tract to identify novel inhibitors of Proteus mirabilis urease activity
利用插管尿路中的多种微生物相互作用来鉴定奇异变形杆菌尿素酶活性的新型抑制剂
- 批准号:
10678389 - 财政年份:2023
- 资助金额:
$ 20.74万 - 项目类别:
Machine Learning Based Differential Mobility Spectrometry Library Development
基于机器学习的差分迁移谱库开发
- 批准号:
10696533 - 财政年份:2023
- 资助金额:
$ 20.74万 - 项目类别:
BCX-Africa: Utilizing data science to evaluate the applicability of blood cell traits polygenic risk scores for disease prediction in Africa
BCX-Africa:利用数据科学评估血细胞性状多基因风险评分在非洲疾病预测中的适用性
- 批准号:
10714228 - 财政年份:2023
- 资助金额:
$ 20.74万 - 项目类别: